Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment - A national drug abuse treatment clinical trials network study

被引:249
|
作者
Peirce, JM
Petry, NM
Stitzer, ML
Blaine, J
Kellogg, S
Satterfield, F
Schwartz, M
Krasnansky, J
Pencer, E
Silva-Vazquez, L
Kirby, KC
Roger-Malvestuto, C
Roll, JM
Cohen, A
Copersino, ML
Kolodner, K
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Connecticut, Sch Med, New Haven, CT USA
[3] Biopharmaceut Res Consultants Inc, Ann Arbor, MI USA
[4] NYU, New York, NY USA
[5] Rockefeller Univ, New York, NY 10021 USA
[6] Univ Penn, Philadelphia, PA 19104 USA
[7] Treatment Res Inst, Philadelphia, PA USA
[8] Washington State Univ, Washington Inst Mental Illness Res & Training, Spokane, WA USA
[9] Univ Calif Los Angeles, Los Angeles, CA USA
[10] NIDA, Intramural Res Program, Baltimore, MD USA
关键词
D O I
10.1001/archpsyc.63.2.201
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Contingency management interventions that provide tangible incentives based on objective indicators of drug abstinence have improved treatment outcomes of substance abusers, but have not been widely implemented in community drug abuse treatment settings. Objective: To compare outcomes achieved when a lower-cost prize-based contingency management treatment is added to usual care in community methadone hydrochloride maintenance treatment settings. Design: Random assignment to usual care with (n = 198) or without (n = 190) abstinence incentives during a 12-week trial. Setting: Six community-based methadone maintenance drug abuse treatment clinics in locations across the United States. Participants: Three hundred eighty-eight stimulant-abusing patients enrolled in methadone maintenance programs for at least 1 month and no more than 3 years. Intervention: Participants submitting stimulant- and alcohol-negative samples earned draws for a chance to win prizes; the number of draws earned increased with continuous abstinence time. Main Outcome Measures: Total number of stimulant- and alcohol-negative samples provided, percentage of stimulant- and alcohol-negative samples provided, longest duration of abstinence, retention, and counseling attendance. Results: Submission of stimulant- and alcohol-negative samples was twice as likely for incentive as for usual care group participants (odds ratio, 1.98; 95% confidence interval, 1.42-2.77). Achieving 4 or more, 8 or more, and 12 weeks of continuous abstinence was approximately 3, 9, and 11 times more likely, respectively, for incentive vs usual care participants. Groups did not differ on study retention or counseling attendance. The average cost of prizes was $120 per participant. Conclusion: An abstinence incentive approach that paid $120 in prizes per participant effectively increased stimulant abstinence in community-based methadone maintenance treatment clinics.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 50 条
  • [21] The construct and measurement equivalence of cocaine and opioid dependences: A National Drug Abuse Treatment Clinical Trials Network (CTN) study
    Wu, Li-Tzy
    Pan, Jeng-Jong
    Blazer, Dan G.
    Tai, Betty
    Brooner, Robert K.
    Stitzer, Maxine L.
    Patkar, Ashwin A.
    Blaine, Jack D.
    DRUG AND ALCOHOL DEPENDENCE, 2009, 103 (03) : 114 - 123
  • [22] An Item Response Theory Modeling of Alcohol and Marijuana Dependences: A National Drug Abuse Treatment Clinical Trials Network Study
    Wu, Li-Tzy
    Pan, Jeng-Jong
    Blazer, Dan G.
    Tai, Betty
    Stitzer, Maxne L.
    Brooner, Robert K.
    Woody, George E.
    Patkar, Ashwin A.
    Blaine, Jack D.
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2009, 70 (03) : 414 - 425
  • [23] Effectiveness of a Clinical Pathway With Methadone Treatment Protocol for Treatment of Neonatal Abstinence Syndrome Following In Utero Drug Exposure to Substances of Abuse
    Bhatt-Mehta, Varsha
    Ng, Chee M.
    Schumacher, Robert E.
    PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (02) : 162 - 169
  • [24] Drug abuse and responsible fathering: a comparative study of men enrolled in methadone maintenance treatment
    McMahon, Thomas J.
    Winkel, Justin D.
    Rounsaville, Bruce J.
    ADDICTION, 2008, 103 (02) : 269 - 283
  • [25] A Systematic Scoping Review of Research on Black Participants in the National Drug Abuse Treatment Clinical Trials Network
    Montgomery, LaTrice
    Burlew, Ann Kathleen
    Haeny, Angela M.
    Jones, Chizara A.
    PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2020, 34 (01) : 117 - 127
  • [26] Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network
    Forman, RF
    Svikis, D
    Montoya, ID
    Blaine, J
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2004, 27 (01) : 1 - 8
  • [27] Direct care workers in the national drug abuse treatment clinical trials network: Characteristics, opinions, and beliefs
    McCarty, Dennis
    Fuller, Bret E.
    Arfken, Cynthia
    Miller, Michael
    Nunes, Edward V.
    Edmundson, Eldon
    Copersino, Marc
    Floyd, Anthony
    Forman, Robert
    Laws, Reesa
    Magruder, Kathy M.
    Oyama, Mark
    Prather, Kristi
    Sindelar, Jody
    Wendt, William W.
    PSYCHIATRIC SERVICES, 2007, 58 (02) : 181 - 190
  • [28] The training documentation form - Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)
    Williams, Tracee
    Kondapaka, Radhika
    Shmueli-Blumberg, Dikla
    Wright, Matthew
    Salazar, Dagmar
    Williams, Kayla
    Collins, Julia
    Jelstrom, Eve
    Lindblad, Robert
    TRIALS, 2017, 18
  • [29] Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study
    McClure, Erin A.
    Campbell, Aimee N. C.
    Pavlicova, Martina
    Hu, Meichen
    Winhusen, Theresa
    Vandrey, Ryan G.
    Ruglass, Lesia M.
    Covey, Lirio S.
    Stitzer, Maxine L.
    Kyle, Tiffany L.
    Nunes, Edward V.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 53 : 39 - 46
  • [30] A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network
    Roman, Paul M.
    Abraham, Amanda J.
    Rothrauff, Tanja C.
    Knudsen, Hannah K.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2010, 38 (04) : S44 - S52